Testosterone Lawsuit Claims Center


 

A range of hormone-raising treatments prescribed to millions of men in the U.S. have recently come under fire by testosterone lawsuit claimants who allegedly experienced strokes, heart attacks and other life-threatening injuries. Our Firm is urging individuals who may have taken these hormone-raising medications, which are also known as “Low T” treatments, to call today for a free and confidential case evaluation.

These medications are marketed in gel, patch, injectable and pellet forms and have been approved by the U.S. Food and Drug Administration (FDA) to treat abnormally-low levels of testosterone in conjunction with an underlying medical condition. A number of testosterone gel lawsuit filings, however, allege that these medications were aggressively marketed for off-label uses to turn over greater profit.

As litigation involving AndroGel, Testim and other popular “Low T” treatments continues to grow, attorneys at Bernstein Liebhard LLP are investigating claims from men who received the medications. Call a testosterone lawyer to learn if you may be eligible to receive compensation for lost wages, out-of-pocket medical expenses and other damages.

Testosterone Lawsuit

Following an FDA notice on January 31, 2014 that alerted the public of its “Low T” treatment safety review, court documents show several testosterone lawsuits pending in jurisdictions throughout the U.S. Among other things, the federal agency vowed to investigate possible heart side effects associated with the hormone-raising medications after two studies found an increased risk for problems in men with preexisting issues.

Doctors have been advised to weigh pros and cons of “Low T” medications when treating patients with low testosterone levels, which may include but are not limited to:

  • AndroGel
  • Testopel
  • Androderm
  • Striant
  • Axiron
  • Bio-T-Gel
  • Delatestryl
  • Depo-Testosterone
  • Fortesta

How Can a Testosterone Lawyer Help You?

Our Firm’s testosterone lawyer practice group is actively monitoring updates in the growing litigation of claims that have been filed since January 2014. Just a week after the FDA’s alert, four AndroGel-related suits were filed in the U.S. District Court, Northern District of Illinois on behalf of men who allegedly experienced strokes, heart attacks, heart failure and other complications stemming from use of the medications. A fifth case against AndroGel was filed on February 10th by a plaintiff alleging pulmonary embolism, deep vein thrombosis, and other serious cardiovascular injuries caused by multiple doses of the drug.

On March 10th, a testosterone gel lawsuit from a man who blames the makers of AndroGel for the stroke he experienced in 2011 joined others pending in the Northern District of Illinois. All these claimants allege that testosterone treatments were prescribed for fatigue, low libido, and other symptoms normally associated with aging, and that their manufacturers engaged in “disease mongering” to further sales.

Testosterone Lawyer Groups File Claims in Wake of “Low T” Findings

A New York Times report from February 2014 indicates that “Low T” scripts are on the rise. Between 2001 and 2011, four times the amount of men over 40 were prescribed the treatments, according to the article, which also said that one in 25 individuals older than 60 is currently taking a prescription therapy.  Testosterone attorney groups representing plaintiffs in claims against AndroGel and other drugs point to research published weeks before the FDA’s January alert that showed an increased testosterone heart attack risk in men under the age of 65 with a history of heart disease. According to the study, which was published in the medical journal, PLoS One, all older men were shown to be at an increased risk, regardless of medical history.

The Journal of the American Medical Association relayed similar findings in November 2013 after looking at data from men who had undergone coronary angiography over a six-year period. Of 8,709 men included in the study, patients taking “Low T” medications were 30 times more likely to suffer a heart attack, stroke or death. 1,233 men involved in the research had been taking a testosterone therapy treatment.

Filing a Testosterone Gel Lawsuit

If you experienced a stroke, heart attack or another cardiovascular side effect after taking one of the above “Low T” treatment therapies, you may be eligible to receive compensation from its manufacturer. Call our Firm to receive a free and confidential evaluation of your case at .

About Our Lawyers

Since 1993, our lawyers have recovered more than $3 billion on behalf of injured victims, including patients harmed by defective drugs and medical devices. Should you choose Bernstein Liebhard LLP to represent you in your lawsuit, you will have a highly experienced team of attorneys, paralegals and investigators on your side, all committed to protecting your legal rights and working to ensure your physical, emotional and financial recovery.